Neurology Minute

Dr. Justin Abbatemarco discusses Adrenoleukodystrophy (ALD).  

Dr. Michael Kentris discusses psychogenic non-epileptic spells [PNES].

Dr. Antoine Gavoille discusses the prognostic factors and efficacy of immunosuppressive treatments for spinal cord sarcoidosis. Show references: https://n.neurology.org/content/98/14/e1479

Show references:

Dr. Shuvro Roy discusses TNF-alpha Antagonism.

Dr. Shuvro Roy discusses CTLA4 Haploinsufficiency.

Audrey Blazek, a 4th-year medical student at Rush Medical College, discusses her abstract, "Combined Prophylactic Treatment of Chronic Migraine with OnabotulinumtoxinA and Anti-CGRP Monoclonal Antibodies". Show references: https://index.mirasmart.com/aan2022/PDFfiles/AAN2022-000014.html

Dr. Mark Keezer discusses the risk of sudden death and cardiac arrhythmia in patients utilizing lamotrigine to treat epilepsy.  Show references:https://n.neurology.org/content/early/2022/03/08/WNL.0000000000200164

Dr. Michael Fox discusses whether connectivity between sites of deep brain stimulation (DBS) and other brain regions is associated with DBS-induced cognitive decline in patients with Parkinson's disease. Show references: https://academic.oup.com/brain/advance-article/doi/10.1093/brain/awac012/6509276?login=false

In part 2 of a 2 part series, Elaine Wirrell, MD, FRCP(C), FAAN, discusses her article, "Evaluation of First Seizure and Newly Diagnosed Epilepsy" from the April Continuum Epilepsy issue. This article and the accompanying Continuum Audio interview are open to all until July 1, 2022, at http://continpub.com/EvalFirstSeiz.

In part 1 of a 2 part series, Elaine Wirrell, MD, FRCP(C), FAAN, discusses her article, "Evaluation of First Seizure and Newly Diagnosed Epilepsy" from the April Continuum Epilepsy issue. This article and the accompanying Continuum Audio interview are open to all until July 1, 2022, at http://continpub.com/EvalFirstSeiz.

Dr. Zafer Keser reviews the article, "Stroke Prevention in Symptomatic Large Artery Intracranial Atherosclerosis Practice Advisory" published in the March 21, 2022, Neurology Journal. Show references: https://n.neurology.org/content/98/12/486

Dr. Gregg Day discusses amyloid-targeting treatments for Alzheimer's disease as well as how to navigate conversations about aducanumab with patients.

Dr. Purdue-Smithe discusses her abstract, "Pre-pregnancy migraine and risk of adverse pregnancy outcomes". Show references: https://index.mirasmart.com/aan2022/PDFfiles/AAN2022-000412.html

Dr. Matthew Hart discusses his abstract, "Hospital Teleneurology Role Leads to Significant Wait Time Reduction for Follow Up Appointments and Increased Access to Subspecialists". Show references: https://index.mirasmart.com/aan2022/PDFfiles/AAN2022-002138.html    

Dr. Erika Peterson discusses her abstract, "Durability of 10-kHz Spinal Cord Stimulation for Painful Diabetic Neuropathy: 18-Month Multicenter Randomized Controlled Trial Results"   Show references: https://index.mirasmart.com/aan2022/PDFfiles/AAN2022-003466.html  

Dr. Barbara Decker discusses maternal obstetric complications and non-elective postpartum readmissions in women with prior stroke, migraine, multiple sclerosis, and myasthenia gravis. Show references: https://n.neurology.org/content/early/2022/02/15/WNL.0000000000200007  

In part 2 of a 2 part series, Marco Mula, MD, PhD, FRCP, FEAN, discusses his article, "Neuropsychiatric and Cognitive Comorbidities in Epilepsy" from the April Continuum Epilepsy issue. This article and the accompanying Continuum Audio interview are available to subscribers at continpub.com/PsychCogEpilepsy.